Month: April 2018

Bringing the next generation of replicon RNA vaccines to the world

Bringing the next generation of replicon RNA vaccines to the world

Tiba is a Boston-based biotechnology startup with a mission to create a new generation of vaccines and immunotherapies for human and animal disease. We bridge expertise in synthetic biology and chemistry to bring a safer, more potent, and more cost-effective product to the market. Our vision is a world where […]